ConductScience.org, home

Gene · 8322

NIH grants1,421

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleFZD4 papersNewest fiscal year
ZIACL080017IQGAP1 in tumorigenesis22025
DP5OD036136Identifying, Characterizing, and Targeting Regulators of B Cell Activation12025
I01BX001957Reprogramming tumor associated macrophages to induce anti-tumor immune responses in bone metastatic breast cancer.12025
I01BX003724Endocrine Actions of Sclerostin12025
I01CX002308Planar Cell Polarity Control in Melanoma Metastasis12025
K01AA029474The role of PDK4 in alcohol-associated liver disease12025
K12CA167540Washington University Paul Calabresi K12 Career Development Award for Clinical Oncology12025
K12CA215110YALE CANCER CENTER CALABRESI IMMUNO-ONCOLOGY TRAINING PROGRAM12025
K12EY022299Michigan Vision Clinician Scientist Development Program12025
K12GM068524San Diego IRACDA Scholars Program12025
K12HD001264Women's Reproductive Health Research at the University of Washington12025
KL2TR001862Institutional Career Development Core12025
P01AG036675Kynurenine accumulation drives loss of muscle and bone function with aging12025
P01CA163222Targetable epigenetic and transcriptional mechanisms in melanoma thatshape the microenvironment12025
P01CA163227Androgen Receptor Action in Castration Resistant Prostate Cancer12025
P20GM103436IDeA Networks of Biomedical Research Excellence in Kentucky12025
P30AG066444Alzheimer's Disease Research Center12025
P30AI050410The University of North Carolina Center for AIDS Research12025
P30AR070155RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGY12025
P30CA008748Cancer Center Support Grant12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/8322/grants?page=4